阿片类药物对前额叶皮层细胞和电路的调节
Rebecca H Cole1, Khaled Moussawi1, Max E Joffe1
1Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, 15219, USA; Translational Neuroscience Program, University of Pittsburgh, Pittsburgh, PA, USA; Center for Neuroscience University of Pittsburgh, Pittsburgh, PA, USA.
Neuropharmacology
|February 28, 2024
概括
在前额叶皮质 (PFC) 中失调的阿片类药物信号传递有助于精神疾病. 针对这个系统为诸如成和抑郁症等疾病提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 前额叶皮层 (PFC) 整合了神经化学系统,这些系统对认知和动机行为至关重要.
- 内源性阿片类和受体在PFC中形成一个复杂的网络,调节奖励,动机,情绪和应激适应.
- 皮质阿片类药物信号的改变与精神疾病的发展有关.
研究的目的:
- 审查证据,将失调的皮质阿片类药物信号与精神疾病联系起来.
- 探索内源性和外源性阿片类药物在调节PFC功能中的作用.
- 突出针对精神疾病的内源性阿片类药物系统的治疗潜力.
主要方法:
- 关于皮质阿片类系统和精神疾病的当前科学文献的综述.
- 对人类患者中阿片类药物表达和活性变化的临床报告的综合.
- 摘要:阿片类药物治疗开发的最新进展.
主要成果:
- 皮质阿片类系统是奖励,动机,情感行为和应激反应的关键基质.
- 有证据表明,这种系统的失调与各种精神疾病的发病有关.
- 临床数据表明精神病患者的阿片类和受体活性发生变化.
结论:
- 在PFC中的内源性阿片类系统在调节与精神疾病相关的行为方面发挥着至关重要的作用.
- 皮质阿片类药物信号的功能障碍与精神疾病的病理生理学有关.
- 针对内源性阿片类药物途径为新型精神病治疗提供了一个有希望的途径.
相关概念视频
Opioid Receptors: Overview
808
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
808
Analgesia and Pain Management
618
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
618
Opioid Analgesics: Synthetic and Semisynthetic Opioids
295
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
295
Opioid Analgesics: Morphine and Other Natural Cogeners
249
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
249
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
193
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
193
Drug Abuse and Addiction: Pharmacological Phenomena
472
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
472


